Candriam SCA’s Nektar Therapeutics NKTR Stock Holding History

Candriam SCA’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,306	Closed	-$103K	–	699
2024 Q3	$103K	Hold	5,306	–	–	﹤0.01%	681
2024 Q2	$98.7K	Buy	+5,306	New	+$98.7K	﹤0.01%	686
2023 Q1	–	Sell	-39,729	Closed	-$1.35M	–	910
2022 Q4	$1.35M	Sell	39,729 -6,000	-13%	-$203K	0.01%	652
2022 Q3	$2.2M	Hold	45,729	–	–	0.02%	564
2022 Q2	$2.61M	Hold	45,729	–	–	0.02%	446
2022 Q1	$3.7M	Buy	+45,729	New	+$3.7M	0.03%	407
2021 Q2	–	Sell	-20,406	Closed	-$5M	–	926
2021 Q1	$5M	Hold	20,406	–	–	0.04%	375
2020 Q4	$5.2M	Sell	20,406 -656	-3%	-$167K	0.04%	384
2020 Q3	$5.24M	Hold	21,062	–	–	0.05%	348
2020 Q2	$7.32M	Sell	21,062 -4,671	-18%	-$1.62M	0.08%	265
2020 Q1	$8.15M	Hold	25,733	–	–	0.09%	252
2019 Q4	$8.33M	Sell	25,733 -267	-1%	-$86.5K	0.09%	256
2019 Q3	$7.1M	Sell	26,000 -1,283	-5%	-$351K	0.09%	248
2019 Q2	$14.5M	Sell	27,283 -1,303	-5%	-$692K	0.18%	132
2019 Q1	$14.4M	Sell	28,586 -1,161	-4%	-$585K	0.18%	123
2018 Q4	$14.7M	Buy	29,747 +500	+2%	+$247K	0.23%	102
2018 Q3	$26.7M	Buy	29,247 +20,128	+221%	+$18.4M	0.36%	57
2018 Q2	$6.68M	Buy	+9,119	New	+$6.68M	0.11%	244
2018 Q1	–	Sell	-10,733	Closed	-$9.62M	–	778
2017 Q4	$9.62M	Sell	10,733 -6,594	-38%	-$5.91M	0.17%	157
2017 Q3	$6.24M	Buy	17,327 +1,927	+13%	+$694K	0.11%	230
2017 Q2	$4.52M	Buy	15,400 +9,067	+143%	+$2.66M	0.08%	279
2017 Q1	$2.23M	Sell	6,333 -5,334	-46%	-$1.88M	0.04%	423
2016 Q4	$2.15M	Sell	11,667 -1,666	-12%	-$307K	0.05%	357
2016 Q3	$3.44M	Sell	13,333 -6,867	-34%	-$1.77M	0.08%	257
2016 Q2	$4.31M	Sell	20,200 -7,133	-26%	-$1.52M	0.11%	206
2016 Q1	$5.61M	Sell	27,333 -6,014	-18%	-$1.23M	0.14%	175
2015 Q4	$8.43M	Sell	33,347 -7,533	-18%	-$1.9M	0.23%	117
2015 Q3	$6.72M	Buy	40,880 +11,547	+39%	+$1.9M	0.17%	160
2015 Q2	$5.5M	Buy	29,333 +8,000	+38%	+$1.5M	0.11%	223
2015 Q1	$3.52M	Buy	21,333 +1,000	+5%	+$165K	0.07%	309
2014 Q4	$4.73M	Buy	+20,333	New	+$4.73M	0.1%	240